{"Abstract": [0], "Cancer-associated": [1], "fibroblasts": [2], "(CAFs),": [3], "a": [4], "stromal": [5], "cell": [6, 97], "population": [7], "with": [8, 38, 106, 116, 173], "cell-of-origin,": [9], "phenotypic": [10], "and": [11, 35, 43, 59, 64, 73, 102, 139, 163, 194, 199, 203, 224], "functional": [12], "heterogeneity,": [13], "are": [14], "the": [15, 20, 51, 55, 68, 74, 107, 112, 127, 130, 156, 168, 192, 206, 214, 234], "most": [16], "essential": [17], "components": [18, 125], "of": [19, 54, 71, 94, 132, 155, 161], "tumor": [21, 31, 60, 75, 88, 100], "microenvironment": [22, 77, 165], "(TME).": [23], "Through": [24], "multiple": [25], "pathways,": [26], "activated": [27], "CAFs": [28, 58, 72, 114, 162, 172, 198, 212], "can": [29], "promote": [30], "growth,": [32], "angiogenesis,": [33], "invasion": [34], "metastasis,": [36], "along": [37], "extracellular": [39], "matrix": [40], "(ECM)": [41], "remodeling": [42], "even": [44], "chemoresistance.": [45], "Numerous": [46], "previous": [47], "studies": [48, 160], "have": [49, 79], "confirmed": [50], "critical": [52], "role": [53], "interaction": [56], "between": [57, 197], "cells": [61, 119, 151, 202], "in": [62, 86, 99, 111, 213, 233], "tumorigenesis": [63], "development.": [65], "However,": [66], "recently,": [67], "mutual": [69], "effects": [70], "immune": [76, 96, 118, 124, 157, 164, 174, 201], "(TIME)": [78], "been": [80], "identified": [81], "as": [82, 120, 122], "another": [83], "key": [84], "factor": [85], "promoting": [87], "progression.": [89], "The": [90], "TIME": [91, 128], "mainly": [92], "consists": [93], "distinct": [95], "populations": [98], "islets": [101], "is": [103], "highly": [104], "associated": [105], "antitumor": [108], "immunological": [109], "state": [110], "TME.": [113, 215], "interact": [115], "tumor-infiltrating": [117], "well": [121], "other": [123, 140], "within": [126], "via": [129], "secretion": [131], "various": [133], "cytokines,": [134], "growth": [135], "factors,": [136], "chemokines,": [137], "exosomes": [138], "effector": [141], "molecules,": [142], "consequently": [143], "shaping": [144], "an": [145], "immunosuppressive": [146], "TME": [147], "that": [148], "enables": [149], "cancer": [150], "to": [152], "evade": [153], "surveillance": [154], "system.": [158], "In-depth": [159], "interactions,": [166], "particularly": [167], "complicated": [169], "mechanisms": [170, 209], "connecting": [171], "cells,": [175], "might": [176], "provide": [177], "novel": [178], "strategies": [179], "for": [180], "subsequent": [181], "targeted": [182], "immunotherapies.": [183], "Herein,": [184], "we": [185, 218], "shed": [186], "light": [187], "on": [188, 230], "recent": [189], "advances": [190], "regarding": [191], "direct": [193], "indirect": [195], "crosstalk": [196], "infiltrating": [200], "further": [204], "summarize": [205], "possible": [207], "immunoinhibitory": [208], "induced": [210], "by": [211], "In": [216], "addition,": [217], "present": [219], "current": [220], "related": [221], "CAF-targeting": [222], "immunotherapies": [223], "briefly": [225], "describe": [226], "some": [227], "future": [228], "perspectives": [229], "CAF": [231], "research": [232], "end.": [235]}